Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:06 PM UTC
| NCT Number | NCT05968898 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | NA |
| Target Enrollment | 300 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 16, 2026: Clinical trial NCT05968898 is currently recruiting participants. This na study for lung cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05968898 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05968898 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.